Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

517 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment goal attainment for secondary prevention in coronary patients with or without diabetes mellitus - Polish multicenter study POLASPIRE.
Haberka M, Jankowski P, Kosior DA, Szpakowicz M, Szóstak-Janiak K, Kozieł P, Krzykwa A, Łapińska M, Setny M, Kamiński K, Kubica A, de Bacquer D, de Backer G, Kotseva K, Wood D, Pająk A, Czarnecka D, Gąsior Z. Haberka M, et al. Among authors: de bacquer d, de backer g. Arch Med Sci. 2020 Jan 23;19(2):305-312. doi: 10.5114/aoms.2020.92558. eCollection 2023. Arch Med Sci. 2020. PMID: 37034537 Free PMC article.
Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys.
Vynckier P, De Sutter J, De Pauw M, Vandekerckhove H, De Backer G, Vervaet P, Deweerdt N, Dendale P, Persu A, Janssen A, Chenu P, Kotseva K, Gevaert S, De Bacquer D, De Smedt D; EUROASPIRE V Investigators Group; EUROASPIRE IV. Vynckier P, et al. Among authors: de backer g. Acta Cardiol. 2023 Jul;78(5):607-613. doi: 10.1080/00015385.2023.2169439. Epub 2023 Feb 13. Acta Cardiol. 2023. PMID: 36779380
Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies.
Ferrannini G, Tuomilehto J, De Backer G, Kotseva K, Mellbin L, Schnell O, Wood D, De Bacquer D, Rydén L. Ferrannini G, et al. Among authors: de backer g. Lancet Diabetes Endocrinol. 2024 Nov;12(11):790-798. doi: 10.1016/S2213-8587(24)00201-8. Epub 2024 Sep 23. Lancet Diabetes Endocrinol. 2024. PMID: 39326426
Variation in secondary prevention of coronary heart disease: the INTERASPIRE study.
McEvoy JW, Jennings C, Kotseva K, De Bacquer D, De Backer G, Erlund I, Vihervaara T, Lip GYH, Ray KK, Rydén L, Abreu A, Almahmeed W, Ambari AM, Ge J, Hasan-Ali H, Huo Y, Jankowski P, Jimenez RM, Li Y, Mahmood Zuhdi AS, Makubi A, Mbakwem AC, Mbau L, Navarro Estrada JL, Ogah OS, Ogola EN, Quintero-Baiz A, Sani MU, Sosa Liprandi MI, Tan JWC, Urina Triana MA, Yeo TJ, Ganly S, Adamska A, Wood D. McEvoy JW, et al. Among authors: de backer g. Eur Heart J. 2024 Oct 14;45(39):4184-4196. doi: 10.1093/eurheartj/ehae558. Eur Heart J. 2024. PMID: 39212219
Prevention of cardiovascular disease: are we successful?
De Backer G. De Backer G. Eur Heart J Open. 2022 Sep 23;2(5):oeac062. doi: 10.1093/ehjopen/oeac062. eCollection 2022 Sep. Eur Heart J Open. 2022. PMID: 36284644 Free PMC article. No abstract available.
517 results